Evidence map›Paper›PMID 28130760›Full record

ArticleFolia microbiologica2017

Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Ivana Shawkatová, Juraj Javor, Zuzana Párnická, Mária Bucová, Daniela Čopíková-Cudráková, Jozef Michalík, Karin Gmitterová, Daniel Čierny, Milan Buc, Vladimíra Ďurmanová

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. The genetic effect of theBioscience reports · 2018
    Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ivana ShawkatováInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia. ivana.shawkatova@fmed.uniba.sk.ORCID http://orcid.org/0000-0002-7803-5815
Juraj JavorInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia.
Zuzana PárnickáInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia.
Mária BucováInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia.
Daniela Čopíková-Cudráková1st Department of Neurology, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
Jozef MichalíkClinic of Neurology, Jessenius Faculty of Medicine in Martin and University Hospital, Comenius University, Martin, Slovakia.
Karin Gmitterová2nd Department of Neurology, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
Daniel ČiernyDepartment of Clinical Biochemistry, Jessenius Faculty of Medicine in Martin and University Hospital, Comenius University, Martin, Slovakia.
Milan BucInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia.
Vladimíra ĎurmanováInstitute of Immunology, Faculty of Medicine, Comenius University, Odborarske nam. 14, 813 72, Bratislava, Slovakia.
Comenius University Bratislava · SKUniversity Hospital Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infiltration of immune cells into CNS is one of the essential events in multiple sclerosis (MS) development. Adhesion molecules like the intercellular adhesion molecule 1 (ICAM-1) play critical role in this process. Therefore, the ICAM1 gene containing two important single-nucleotide polymorphisms (SNPs) belongs to candidate loci with possible involvement in MS susceptibility and/or severity. The objective of our case-control study was to analyze the association of two functional ICAM1 polymorphisms rs1799969 (or G241R) and rs5498 (or K469E) with susceptibility to MS and evaluate their influence on the age at disease onset, severity, neurological disability and progression rate. Two hundred forty-eight MS subjects (mean 39.2 years) and 208 age-matched controls (mean 35.6 years) were involved in the study. Genotyping of ICAM1 rs1799969 and rs5498 SNPs was performed by PCR-RFLP. Presence of the rs3135388 polymorphism tagging the major MS risk allele HLA-DRB1*15:01 allele was determined as well. Our analysis revealed no statistically significant association of ICAM1 polymorphisms with risk of MS development in the Slovak population. Stratification of study cohorts by gender, age at onset and presence of the HLA-DRB1*15:01 risk allele showed only moderate changes. Correlation of clinical findings as age at onset, Kurtzke Expanded Disability Status Scale, Multiple Sclerosis Severity Score and progression index with ICAM1 genotypes in MS patients revealed no significant association; however, patients with earlier onset of MS showed slightly higher frequencies of the homozygous G allele at rs5498 in comparison to other genotypes (P = 0.04), suggesting that GG carriers tend to induce MS at an earlier age.

Indexed as

Polymorphism, Single NucleotideAdultAllelesCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHLA-DRB1 ChainsHumansIntercellular Adhesion Molecule-1MaleMiddle AgedMultiple SclerosisSlovakiaYoung AdultHLA-DRB1 ChainsIntercellular Adhesion Molecule-1

Identifiers

PMID28130760
OpenAlexW2580219523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.